CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Dec. 27, 2019—The FDA authorized marketing of the Cobas VivoDx MRSA (Roche) diagnostic test based on bacterial viability and novel technology to detect methicillin-resistant Staphylococcus aureus bacterial colonization.
Read More »Dec. 27, 2019—The FDA authorized marketing of the Cobas VivoDx MRSA (Roche) diagnostic test based on bacterial viability and novel technology to detect methicillin-resistant Staphylococcus aureus bacterial colonization.
Read More »